Shattuck Labs, Inc. STTK Business Segments — R&D
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Shattuck Labs, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Shattuck Labs, Inc.'s business segments — r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Shattuck Labs, Inc.'s business segments — R&D?
- Shattuck Labs, Inc. (STTK) reported business segments — R&D of $10.95M in Q1 2026.
- How has Shattuck Labs, Inc.'s business segments — R&D changed year-over-year?
- Shattuck Labs, Inc.'s business segments — R&D increased by 10.4% year-over-year, from $9.92M to $10.95M.
- What is the long-term trend for Shattuck Labs, Inc.'s business segments — R&D?
- Over 2 years (2023 to 2025), Shattuck Labs, Inc.'s business segments — R&D has grown at a -31.1% compound annual growth rate (CAGR), from $74.31M to $35.27M.
- What does business segments — R&D mean?
- Aggregates all costs incurred by the segment to advance clinical-stage product candidates, including personnel, laboratory supplies, and clinical trial expenses. It is a primary measure of the company's investment in future therapeutic breakthroughs and pipeline maturity.